This study is accepting new patients by invitation only
Open-Label Extension Study of Trofinetide for Rett Syndrome
Summary
- Eligibility
- for females ages 5-22 (full criteria)
- Location
- at La Jolla, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients by invitation only
- Start Date
- Completion Date
- (estimated)
- Sponsor
- ACADIA Pharmaceuticals Inc.
- ID
- NCT04776746
- Phase
- Phase 3 Rett Syndrome Research Study
- Study Type
- Interventional
- Participants
- Expecting 153 study participants
- Last Updated